Mississippi Rezulin Litigation Lawyer
Rezulin®
Also known as troglitazone, the anti-hyperglycemic drug Rezulin® was approved by the FDA to treat Type 2 diabetes. The drug was recalled in March 2000 because of research that showed that Rezulin® could potentially cause liver failure. Rezulin® distributor and manufacturer, Parke-Davis, a Warner Lambert Company, still maintains that the benefits of Rezulin® outweigh any perceived risks.
If you or a loved one has taken Rezulin® and suffered from any form of liver damage or liver problems, please contact Coxwell & Associates' Jackson Mississippi personal injury lawyers in Jackson, Mississippi.
|